JP Morgan Chase
RANI icon

JP Morgan Chase’s Rani Therapeutics RANI Stock Holding History

JP Morgan Chase’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.45K Sell
7,121
-177
-2% -$157 ﹤0.01% 7048
2026
Q1 		$5.57K Sell
7,298
-521
-7% -$666 ﹤0.01% 6872
2025
Q4 		$10.6K Buy
7,819
+7,748
+10,913% +$11.7K ﹤0.01% 6661
2025
Q3 		$35 Hold
71
– – ﹤0.01% 7248
2025
Q2 		$36 Hold
71
– – ﹤0.01% 6919
2025
Q1 		$89 Hold
71
– – ﹤0.01% 6892
2024
Q4 		$97 Hold
71
– – ﹤0.01% 7011
2024
Q3 		$153 Hold
71
– – ﹤0.01% 6940
2024
Q2 		$270 Sell
71
-12,615
-99% -$65.4K ﹤0.01% 6746
2024
Q1 		$39.5K Buy
12,686
+8,988
+243% +$30.9K ﹤0.01% 6021
2023
Q4 		$12.3K Sell
3,698
-741
-17% -$1.71K ﹤0.01% 6357
2023
Q3 		$9.65K Sell
4,439
-2,086
-32% -$7.97K ﹤0.01% 6269
2023
Q2 		$26.9K Buy
6,525
+5,082
+352% +$23.6K ﹤0.01% 5853
2023
Q1 		$7K Buy
1,443
+654
+83% +$3.93K ﹤0.01% 6190
2022
Q4 		$5K Sell
789
-608
-44% -$4.43K ﹤0.01% 6170
2022
Q3 		$13K Buy
1,397
+209
+18% +$2.21K ﹤0.01% 5919
2022
Q2 		$12K Sell
1,188
-1,141
-49% -$13.1K ﹤0.01% 6004
2022
Q1 		$31K Sell
2,329
-1,857
-44% -$30.8K ﹤0.01% 5955
2021
Q4 		$68K Buy
+4,186
New +$95.1K ﹤0.01% 5833

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase's RANI Position: Q2 2026 in Review

JP Morgan Chase reduced its Rani Therapeutics (RANI) stake by 2.4% in Q2 2026, selling an estimated $157 and leaving 7,121 shares worth $5.45K. The position accounts for ﹤0.01% of the portfolio, ranked #7048.

JP Morgan Chase first reported a position in RANI in Q4 2021 and has held it in 19 quarters since. The position peaked at $68K in Q4 2021. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • JP Morgan Chase held 7,121 shares of Rani Therapeutics worth $5.45K as of Q2 2026.
  • JP Morgan Chase sold 177 Rani Therapeutics shares in Q2 2026, an estimated $157.
  • Rani Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7048 holding.
  • JP Morgan Chase first reported a position in Rani Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Rani Therapeutics position peaked at $68K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.